| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |